Of the top five medical device IPOs of the year, one company's stock price remained flat, which has got to be a disappointing result for an IPO. Another's share price barely rose by 15 cents, while the other two saw share prices drop below the offering price by at least a dollar, a sign of a failed IPO. Only one company - TriVascular Technologies - saw its IPO succeed with a closing stock price on opening day increase by more than a dollar.
Let's hope other medtech companies that go public in the rest of the year fare better.
|Attend the largest medtech event in the East Coast - MD&M East Conference & Expo, June 9-12, in New York City.|